目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 MARKET COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 LIMITATIONS
1.6 MAJOR MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.2.1 PRIMARY SOURCES
2.2.2.2 KEY INDUSTRY INSIGHTS
2.2.2.3 BREAKDOWN OF PRIMARIES
2.3 IMPACT OF RECESSION ON MULTIMODAL IMAGING MARKET
2.4 MARKET SIZE ESTIMATION
2.4.1 REVENUE-MAPPING BASED MARKET ESTIMATION
2.4.2 PROCEDURE BASED MARKET ESTIMATION
2.4.2 PRIMARY RESEARCH VALIDATION
2.5 DATA TRIANGULATION APPROACH
2.6 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.6.1 RESEARCH ASSUMPTIONS
2.6.2 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.2 RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 PORTER’S FIVE FORCES ANALYSIS
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
5.3.2 REGULATORY TRENDS
5.4 REIMBURSEMENT SCENARIO
5.5 ECOSYSTEM COVERAGE
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
5.8.2 AVERAGE SELLING PRICE TREND
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
5.11 TECHNOLOGY ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2023-2024
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
5.14.2 BUYING CRITERIA
5.15 CASE STUDY ANALYSIS

6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY (USD MILLION; 2021—2028)*
6.1 PET/CT SYSTEMS
6.2 SPECT/CT SYSTEMS
6.3 PET/MR SYSTEMS
6.4 OCT/FLUORESCENCE MOLECULAR TOMOGRAPHY (FMT)
6.5 MR/OPTICAL IMAGING
6.6 OTHER MULTIMODAL SYSTEMS

7 MULTIMODAL IMAGING MARKET, BY APPLICATION (USD MILLION; 2021—2028)*
7.1 BRAIN AND NEUROLOGY
7.2 CARDIOLOGY
7.3 ONCOLOGY
7.4 OPHTHALMOLOGY
7.5 RESEARCH APPLICATIONS
7.6 OTHER APPLICATIONS

8 MULTIMODAL IMAGING MARKET, BY END-USER (USD MILLION; 2021—2028)*
8.1 HOSPITALS
8.2 DIAGNOSTIC IMAGING CENTERS
8.3 ACADEMIC AND RESEARCH INSTITUTES
8.4 OTHER END USERS

9 MULTIMODAL IMAGING MARKET, BY REGION (USD MILLION; 2021—2028)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 RECESSION IMPACT
9.3.2 GERMANY
9.3.3 UK
9.3.3 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 RECESSION IMPACT
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 AUSTRALIA
9.4.7 REST OF ASIA-PACIFIC
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT
9.5.2 BRAZIL
9.5.3 MEXICO
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2023)
10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS-2022
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.7 C0MPETITIVE SITUATION AND TRENDS (2021-2023)
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS
10.8 COMPETITIVE BENCHMARKING

11 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2022)***
11.1 GE HEALTHCARE
11.2 KONINKLIJKE PHILIPS N.V.
11.3 CANON MEDICAL SYSTEM CORPORATION
11.4 SIEMENS HELATHINEERS AG
11.5 UNITED IMAGING HEALTHCARE CO., LTD.
11.6 NEUSOFT CORPORATION
11.7 MEDISO LTD.
11.8 SPECTRUM DYNAMICS MEDICAL.
11.9 INFRAREDX, INC.
11.10 TOPCON CORPORATION
11.11 CARL ZEISS AG
11.12 HEIDELBERG ENGINEERING
11.13 BRUKER CORPORATION
11.14 PERKINELMER, INC
11.15 IBM CORPORATION
11.16 ESAOTE S.P.A.
11.17 FONAR CORP
11.18 ECHO-SON S.A.
11.19 POSITRON CORPORATION
11.20 MILABS B.V.
11.21 TOSHIBA CORPORATION.

12 APPENDIX